Differential Expression of Claudin-1, Claudin-3, and Claudin-4 in Bladder Lesions
Journal Title: Journal of Cancer and Tumor International - Year 2015, Vol 2, Issue 3
Abstract
Aims: Claudins are major transmembrane proteins of tight junctions. As the disruption of their function have important impact on tumorogenesis, invasion and metastasis. Claudins became a focus of interest for targeting therapies. Although their expression profiles have been studied in many organs, researches on Claudin expression in bladder are in limited number. The aim of this study is to present the differential expression of Claudin-1, Claudin-3 and Claudin-4 in invasive and noninvasive urothelial lesions. Study of Design: Several groups of noninvasive and invasive urothelial lesions were stained immunohistochemically by Claudin-1, Claudin-3 and Claudin-4 and their expressions were evaluated. Place and Duration of Study: Department of Pathology of Diskapi Research and Training Hospital, Ankara, between 2011-2013. Methodology: 83 cases (31 invasive urothelial carcinomas (IUCC) –further divided into: 15 muscle invasive UCCs, 16 UCCs with lamina propria invasion-, 17 noninvasive papillary urothelial carcinomas (NPUC), 13 papillary urothelial neoplasms of low malignant potential (PUNLMP), 7 carcinoma in situ (CIS) and 15 normal independent samples (CG). Sections from formalin-fixed paraffin embedded tissues were immunohistochemically stained with Claudin 1, Claudin 3 and Claudin 4. Results: Claudin-1 expression is significantly lower in low grade noninvasive urotelial carcinomas compared to invasive carcinomas. Claudin-3 is highly expressed in normal urothelium and invasive lesions; but its expression is decreased significantly in all non-invasive lesions. Claudin-4 expression appeared to decrease in muscle invasive UCC and CIS vs. others. Conclusion: Although higher expression of Claudin-4 in low-grade and non-invasive lesions may be used as a diagnostic tool, decreased expression of Claudin-4 can indicate more invasive capacity of the tumour. In terms of Claudin-1 and -3, their decreased expression in non-invasive lesions when compared to control group and their trend to show more increased expression in IUCC needs to be studied further in larger studies.
Authors and Affiliations
Tuba Dilay Kokenek-Unal, Ipek Coban, Ayse Selcen Oguz-Erdogan, Hatice Seneldir, Nesrin Gurcay, Murat Alper
Keywords
Related Articles
- EP ID EP242966
- DOI 10.9734/JCTI/2015/19336
- Views 99
- Downloads 0
Association of Activated Partial Thromboplastin Time and Fibrinogen Level in Patients with Polycythemia Vera
Aims: To evaluate the Activated Partial Thromboplastin Time (APTT) and fibrinogen levels in patients with Polycythemia vera (PV). Study Design: Analytical, laboratory, hospital-based, cross sectional study. Place and Dur...
Intracranial Hemangiopericytoma in a 15 Year-old Child: Neuroimaging Features and Management Therapy
Introduction: Intracranial hemangiopericytoma (HPR) is a highly vascular tumors which is exceptional in children. They may present management difficulties in some cases. Clinical Presentation: The authors report the case...
Chemotherapy Induced Skin Toxicities and Review of Literature
Chemotherapeutic drugs have proven efficacy in the treatment of most of the cancers. Chemotherapy induced side effects are commonly seen in clinical oncology. Development of new chemotherapeutic drugs and various new pro...
Circulating Prostate Gland Cells in Benign Prostatic Hyperplasia and Adenocarcinoma in Patients of African Heritage: Diagnosis by Liquid Biopsy: Preliminary Results
Background: Benign prostatic hyperplasia and adenocarcinoma are two major urological conditions of the human prostate gland. Benign prostatic hyperplasia is due to increase in stromal cells and adenocarcinoma of the pros...
Evaluation of Cardiac Biomarkers in Detection of Cardiomyopathy Induced by Cardiotoxic Chemotherapeutic Agents
Background: Doxorubicin is a potent chemotherapeutic drug. The clinical usefulness of doxorubicin has been limited largely by the risk of cardiomyopathy and life-threatening heart failure. Therefore early identification...